Startups
The TIGeR-PaC clinical trial is a study of Trans-Arterial Micro-Perfusion (TAMP™) for targeted delivery of chemotherapy to disease sites with a FDA cleared medical device system.
Overview
Location
United States, California, Los Altos
Employees
1-10
Phone
+1 650-284-4433
Total raised
$11.15M
Founded date
2009
Investors 5
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Astia Angels | astia.org | |
| Plug and Play Tech Center | plugandplaytechcenter.com | |
| Dec 1, 2024 | SeedFolio | seedfolio.vc |
| StartX | startx.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 28, 2014 | Series B round | $1.15M |
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 20, 2022 | xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study | RenovoRx's Phase III clinical study is open to pancreatic adenocarcinoma patients and focuses on extending overall survival and improving quality of life. Our therapy platform is challenging the standard-of-care treatment available to local... |
| Oct 4, 2022 | ROTH Capital Partners to Host Inaugural Healthcare Opportunities Conference on October 6th at the Yale Club in New York City | Event to feature company presentations and one-on-one meetings between institutional investors and senior management from select Healthcare companies in Biotechnology, Pharmaceuticals, Medical Technologies, Oncology and Mental Health Therap... |
| Nov 16, 2021 | RenovoRx : Announces Third Quarter 2021 Financial Results - Form 8-K | RenovoRx Announces Third Quarter 2021 Financial Results Los Altos, CA, November 15, 2021 - RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today reported its unaudited financial results f... |
| Sep 7, 2021 | RenovoRx Receives New 510(k) Clearance for its RenovoCath® Delivery System Designed for Targeted Treatment of Solid Tumors | |
| Aug 25, 2021 | RenovoRx Announces Pricing of Initial Public Offering | |
| Jan 20, 2021 | RenovoRx Announces Studies that Further Advance the Science of Pancreatic Cancer Treatment Presented at the 2021 ASCO Gastrointestinal Cancers Symposium | |
| May 23, 2018 | RenovoRx Raises $10M in Financing | RenovoRx, Inc., a Los Altos, Calif.-based medical technology company developing an innovative catheter-based approach to treating pancreatic cancer, raised $10m in financing. The round was led by Boston Scientific with participation from ne... |
| May 23, 2018 | Term Sheet — Wednesday, May 23 | 5 Qs WITH A DEALMAKER Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop “When I looked around, I saw a lot of women who were starting businesses,” she told Term Sheet. “I recognized that in the... |
| May 23, 2018 | Boston Scientific Leads $10M Funding for RenovoRx | LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc., a medical technology company developing an innovative catheter-based approach to treating pancreatic cancer, today announced a $10 million financing round of which the company closed $7 mi... |
Show more
Reviews 0
FAQ about RenovoRx
When was RenovoRx founded?
RenovoRx was founded in 2009.
How much funding has RenovoRx raised?
RenovoRx has raised $11.15M in total across 2 funding rounds.
What funding rounds has RenovoRx raised?
Parsers VC lists 2 funding rounds of RenovoRx, among them a Series B round of $1.15M on Jan 28, 2014.
Who has invested in RenovoRx?
Parsers VC lists 5 investors of RenovoRx, among them SeedFolio, Astia Angels and Plug and Play Tech Center.
What has the press written about RenovoRx?
Parsers VC has collected 12 articles mentioning RenovoRx, among them “xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study” (Dec 20, 2022) and “ROTH Capital Partners to Host Inaugural Healthcare Opportunities Conference on October 6th at the Yale Club in New York City” (Oct 4, 2022).
Is RenovoRx still active?
Yes, RenovoRx is active; its latest activity on Parsers VC dates from Dec 1, 2024.